Immuneering Corp (NASDAQ:IMRX)’s traded shares stood at 0.56 million during the latest session, with the company’s beta value hitting -0.43. At the last check today,
Immuneering Corp (NASDAQ:IMRX) has a beta value of -0.47 and has seen 25.67 million shares traded in the last trading session. The company, currently valued
Immuneering Corp (NASDAQ:IMRX) has a beta value of -0.47 and has seen 16.97 million shares traded in the recent trading session. The company, currently valued
During the last session, Immuneering Corp (NASDAQ:IMRX)’s traded shares were 0.42 million, with the beta value of the company hitting -0.45. At the end of
In the last trading session, 1.14 million shares of the Immuneering Corp (NASDAQ:IMRX) were traded, and its beta was -0.44. Most recently the company’s share
In the last trading session, 1.55 million Immuneering Corp (NASDAQ:IMRX) shares changed hands as the company’s beta touched -0.48. With the company’s per share price
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
